Zejula (niraparib) is a prescription drug used ... or appropriate for all patients or all specific uses. Healthline has strict sourcing guidelines and relies on peer-reviewed studies, academic ...

We may earn commission from links on this page, but we only recommend products we back.

The marketing authorisation for Zejula, a once-daily pill, covers epithelial ovarian, fallopian tube, or primary peritoneal cancer patients in complete response or partial response to platinum ...

In the likely event of approval by the European Commission in the coming weeks, Zejula will have an EU licence as a monotherapy for the maintenance treatment of adult patients with platinum ...